These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12228779)

  • 1. Management of ventricular arrhythmias in diverse populations in California.
    Alexander M; Baker L; Clark C; McDonald KM; Rowell R; Saynina O; Hlatky MA
    Am Heart J; 2002 Sep; 144(3):431-9. PubMed ID: 12228779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Which strategy is "best" after myocardial infarction? The Beta-blocker Strategy plus Implantable Cardioverter Defibrillator Trial: rationale and study design.
    Raviele A; Bongiorni MG; Brignole M; Cappato R; Capucci A; Gaita F; Mangiameli S; Montenero A; Pedretti R; Salerno J; Sermasi S
    Am J Cardiol; 1999 Mar; 83(5B):104D-111D. PubMed ID: 10089851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implantable Cardioverter Defibrillator Utilization and Mortality Among Patients ≥65 Years of Age With a Low Ejection Fraction After Coronary Revascularization.
    Goldstein SA; Li S; Lu D; Matsouaka RA; Rymer J; Fonarow GC; de Lemos JA; Peterson E; Pokorney SD; Wang T; Al-Khatib SM
    Am J Cardiol; 2021 Jan; 138():26-32. PubMed ID: 33068540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term arrhythmia-free survival in patients with severe left ventricular dysfunction and no inducible ventricular tachycardia after myocardial infarction.
    Zaman S; Narayan A; Thiagalingam A; Sivagangabalan G; Thomas S; Ross DL; Kovoor P
    Circulation; 2014 Feb; 129(8):848-54. PubMed ID: 24381209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Cardiac Resynchronization Therapy Among Eligible Patients Receiving an Implantable Cardioverter Defibrillator: Insights From the National Cardiovascular Data Registry Implantable Cardioverter Defibrillator Registry.
    Marzec LN; Peterson PN; Bao H; Curtis JP; Masoudi FA; Varosy PD; Bradley SM
    JAMA Cardiol; 2017 May; 2(5):561-565. PubMed ID: 28122073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes in patients with sustained ventricular tachyarrhythmias occurring within 48 h of acute myocardial infarction: when is ICD appropriate?
    Liang JJ; Hodge DO; Mehta RA; Russo AM; Prasad A; Cha YM
    Europace; 2014 Dec; 16(12):1759-66. PubMed ID: 25100756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study.
    Zaman S; Sivagangabalan G; Chik W; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
    J Interv Card Electrophysiol; 2014 Dec; 41(3):195-202. PubMed ID: 25267274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of surgical revascularization in patients with coronary artery disease and ventricular tachycardia or fibrillation in the Antiarrhythmics Versus Implantable Defibrillators (AVID) Registry.
    Cook JR; Rizo-Patron C; Curtis AB; Gillis AM; Bigger JT; Kutalek SP; Coromilas J; Hofer BI; Powell J; Hallstrom AP;
    Am Heart J; 2002 May; 143(5):821-6. PubMed ID: 12040343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability.
    Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B
    Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Racial disparity in cardiac procedures and mortality among long-term survivors of cardiac arrest.
    Groeneveld PW; Heidenreich PA; Garber AM
    Circulation; 2003 Jul; 108(3):286-91. PubMed ID: 12835222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in hospital treatment of ventricular arrhythmias among Medicare beneficiaries, 1985 to 1995.
    McDonald KM; Hlatky MA; Saynina O; Geppert J; Garber AM; McClellan MB
    Am Heart J; 2002 Sep; 144(3):413-21. PubMed ID: 12228777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance of the electrophysiologic study (EPS)-guided therapy for the secondary prevention of ventricular tachycardia.
    Yuge M; Niwano S; Moriguchi M; Sasaki T; Hirasawa S; Imaki R; Sato D; Izumi T
    Circ J; 2006 Mar; 70(3):268-72. PubMed ID: 16501291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive approach to management of ventricular arrhythmias.
    Kusumoto F
    Cardiol Clin; 2008 Aug; 26(3):481-96, vii. PubMed ID: 18538192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiology studies in patients undergoing ICD implantation: findings from the NCDR®.
    Cheng A; Wang Y; Berger RD; Calkins H; Buxton AE; Curtis JP; Lampert R
    Pacing Clin Electrophysiol; 2012 Aug; 35(8):912-8. PubMed ID: 22670627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Racial disparity in the utilization of implantable-cardioverter defibrillators among patients with prior myocardial infarction and an ejection fraction of Thomas KL; Al-Khatib SM; Kelsey RC; Bush H; Brosius L; Velazquez EJ; Peterson ED; Gilliam FR
    Am J Cardiol; 2007 Sep; 100(6):924-9. PubMed ID: 17826371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries.
    Weiss JP; Saynina O; McDonald KM; McClellan MB; Hlatky MA
    Am J Med; 2002 May; 112(7):519-27. PubMed ID: 12015242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implantable defibrillators for secondary prevention of sudden cardiac death in cardiac surgery patients with perioperative ventricular arrhythmias.
    Nageh MF; Kim JJ; Chen LH; Yao JF
    J Am Heart Assoc; 2014 Aug; 3(4):. PubMed ID: 25146702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implantable cardioverter-defibrillator therapy in patients with ventricular fibrillation out of hospital cardiac arrest secondary to acute coronary syndrome.
    Madhavan M; Friedman PA; Lennon RJ; Prasad A; White RD; Sriram CS; Gulati R; Gersh BJ
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25713292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of baseline electrophysiology studies in patients with sustained ventricular tachyarrhythmia: the Antiarrhythmics Versus Implantable Defibrillators (AVID) trial.
    Brodsky MA; Mitchell LB; Halperin BD; Raitt MH; Hallstrom AP;
    Am Heart J; 2002 Sep; 144(3):478-84. PubMed ID: 12228785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
    Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
    Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.